Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
ExportLink to record
Permanent link

Direct link
BETA

Project

Project type/Form of grant
Project grant
Title [sv]
Design av kemiska verktyg för utveckling av läkemedel bortom ¬®regeln om 5¬®
Title [en]
Design of chemical tools for drug discovery beyond the ¨rule of 5¨
Abstract [en]
Many novel targets, in particular protein-protein interactions (PPIs), cannot be modulated with small drug-like molecules. Instead, compounds in a different chemical space, e.g. macrocycles and peptides, are required. This research program deals with how ligands for difficult targets should be designed, and their subsequent use in studies of molecular recognition in three related projects.- We have challenged the dogma that drugs must obey Lipinski’s rule of 5 (Ro5) and have deduced guidelines for design of compounds far beyond the Ro5 (bRo5) that combine potent binding to difficult targets with cell permeability. We will now develop predictive models for cell permeability in bRo5 space and design compounds that modulate PPIs involved in e.g. cancer and atherosclerosis.- C-peptide has beneficial effects in chronic kidney disease (CKD) and we will use state of the art imaging and biochemical techniques to determine its mechanism of action, then decide if C-peptide is of interest for further studies of CKD.- We have found that a glycopeptide from type II collagen (CII) has a key role in pathogenesis of rheumatoid arthritis (RA), and that it can be used to cure disease in a mouse model. Recent results also suggest that antibody recognition of epitopes on cartilage proteins, like CII, may be predictive for development of RA. We will now develop glycopeptide-based vaccines to treat RA and diagnostics based on synthetic mini-CII proteins fo
Publications (1 of 1) Show all publications
Poongavanam, V., Atilaw, Y., Siegel, S., Giese, A., Lehmann, L., Meibom, D., . . . Kihlberg, J. (2022). Linker-Dependent Folding Rationalizes PROTAC Cell Permeability. Journal of Medicinal Chemistry, 65(19), 13029-13040
Open this publication in new window or tab >>Linker-Dependent Folding Rationalizes PROTAC Cell Permeability
Show others...
2022 (English)In: Journal of Medicinal Chemistry, ISSN 0022-2623, E-ISSN 1520-4804, Vol. 65, no 19, p. 13029-13040Article in journal (Refereed) Published
Abstract [en]

Proteolysis-targeting chimeras (PROTACs) must be cell permeable to reach their target proteins. This is challenging as the bivalent structure of PROTACs puts them in chemical space at, or beyond, the outer limits of oral druggable space. We used NMR spectroscopy and molecular dynamics (MD) simulations independently to gain insights into the origin of the differences in cell permeability displayed by three flexible cereblon PROTACs having closely related structures. Both methods revealed that the propensity of the PROTACs to adopt folded conformations with a low solvent-accessible 3D polar surface area in an apolar environment is correlated to high cell permeability. The chemical nature and the flexibility of the linker were essential for the PROTACs to populate folded conformations stabilized by intramolecular hydrogen bonds, pi-pi interactions, and van der Waals interactions. We conclude that MD simulations may be used for the prospective ranking of cell permeability in the design of cereblon PROTACs.

Place, publisher, year, edition, pages
American Chemical Society (ACS), 2022
National Category
Physical Chemistry
Identifiers
urn:nbn:se:uu:diva-488227 (URN)10.1021/acs.jmedchem.2c00877 (DOI)000863621500001 ()36170570 (PubMedID)2-s2.0-85139179763 (Scopus ID)
Funder
Swedish Research Council, 2016-05160Swedish National Infrastructure for Computing (SNIC), SNIC 2019/3-295Swedish National Infrastructure for Computing (SNIC), SNIC2020/5-435Swedish National Infrastructure for Computing (SNIC), SNIC2021/22-244
Available from: 2022-11-14 Created: 2022-11-14 Last updated: 2025-06-18Bibliographically approved
Principal InvestigatorKihlberg, Jan
Coordinating organisation
Uppsala University
Funder
Period
2017-01-01 - 2020-12-31
National Category
Organic ChemistryMedicinal Chemistry
Identifiers
DiVA, id: project:6014Project, id: 2016-05160_VR

Search in DiVA

Organic ChemistryMedicinal Chemistry

Search outside of DiVA

GoogleGoogle Scholar